RetinalGenix Technologies (RTGN) Equity Average (2020 - 2026)

RetinalGenix Technologies' Equity Average history runs 7 years deep, the most recent figure standing at -$2.4 million for Q1 2026.

• In Q1 2026, Equity Average fell 55.27% year-over-year to -$2.4 million; the TTM figure through Mar 2026 stood at -$2.4 million (down 55.27% YoY), while the FY2025 annual figure was -$1.9 million, down 31.27% from the prior year.
• Equity Average came in at -$2.4 million for Q1 2026 at RetinalGenix Technologies, down from -$2.2 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of -$594499.0 in Q1 2022 to a low of -$2.4 million in Q1 2026.
• A 5-year average of -$1.5 million and a median of -$1.6 million in 2025 frame the typical range for Equity Average.
• Across the five-year window, Equity Average plunged 382.26% in 2022 and decreased 1.65% in 2024, its largest moves.
• RetinalGenix Technologies' Equity Average stood at -$1.1 million in 2022, then dropped by 16.92% to -$1.2 million in 2023, then tumbled by 33.31% to -$1.7 million in 2024, then plunged by 34.92% to -$2.2 million in 2025, then decreased by 8.61% to -$2.4 million in 2026.
• According to Business Quant data, Equity Average over the past three periods registered -$2.4 million, -$2.2 million, and -$2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison